XPeng Inc.
NYSE:XPEVAuto - Manufacturers
-$0.40 today
- Market cap
- $9.25B
- Beta
- 1.08
- P/E (TTM)
- -37.8
- EPS (TTM)
- -$1.18
Volume 8.06M
Average 6.75M
XPEV Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
XPeng Inc.NYSE: XPEV
Cash & Equivalents · Q3 FY2026 · quarter ended Sep 2026
Cash & equivalents rises 9.7% from a year ago
Cash & equivalents stood at CN¥19.24B at the end of Q3 FY2026, up 9.7% from a year earlier and down 9.1% from the prior quarter. Over 3 fiscal years it compounded at +5.9% a year.
Context
- Cash & equivalents amounted to 17.0% of total assets at the end of Q3 FY2026, down 0.9 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +9.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
CNY · from the balance sheet
- Latest · FY2025
- 17.33B CNY
- Year-over-year change
- -6.8%
- 4-year CAGR
- +12.0%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 17.33B | -6.8% |
| FY2024 | 2024-12-31 | 18.59B | -12.0% |
| FY2023 | 2023-12-31 | 21.13B | +44.6% |
| FY2022 | 2022-12-31 | 14.61B | +32.5% |
| FY2021 | 2021-12-31 | 11.02B | — |
Cash & Equivalents vs competitors
How XPEV compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +9.7% is the 4th highest of 11, against a peer median of -12.3%.
- Cash & equivalents amounts to 17.0% of total assets for XPEV, versus a peer median of 10.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | ¥10.27T JPY | +25.1% | +19.1% | 10.1% | |
| Mar 2026 | ₫5.51T VND | +129.5% | +19.8% | 3.0% | |
| Jun 2026 | CN¥40.15B CNY | -19.4% | +13.8% | 28.5% | |
| Jun 2026 | CN¥30.98B CNY | +335.6% | +9.4% | 22.7% | |
| Sep 2026 | $23.2B USD | +1.2% | +3.0% | 8.0% | |
| Sep 2026 | CN¥19.24B CNY | +9.7% | +5.9% | 17.0% | |
| Jun 2026 | $18.6B USD | -19.2% | -2.4% | 6.5% | |
| Sep 2026 | $17.85B USD | -5.4% | +0.5% | 11.3% | |
| Jun 2026 | $3.59B USD | -25.4% | -32.4% | 23.7% | |
| Mar 2026 | $738.89M USD | -60.2% | -16.9% | 9.9% | |
| Dec 2025 | $73.43M USD | -28.8% | -53.7% | 3.8% | |
| Peer median (excluding XPEV) | — | -12.3% | +1.8% | 10.0% | |
Competitors are the stored peer set for XPEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 11.02B | 14.61B | 21.13B | 18.59B | 17.33B |
| Short-term Investments | 28.69B | 16.61B | 17.59B | 14.14B | 17.63B |
| Net Receivables | 4.16B | 6.61B | 6.18B | 7.33B | 9.16B |
| Inventory | 2.66B | 4.52B | 5.53B | 5.56B | 10.38B |
| Other Current Assets | 911.04M | 495.26M | 3.57B | 3.63B | 7.57B |
| Total Current Assets | 48.83B | 43.53B | 54.52B | 49.74B | 63.25B |
| Property, Plant & Equipment (Net) | 7.01B | 12.61B | 12.53B | 12.79B | 17.26B |
| Goodwill | 0 | 0 | 34.11M | 34.11M | 34.11M |
| Intangible Assets | 2.98B | 3.79B | 7.74B | 7.35B | 7.47B |
| Long-term Investments | 1.55B | 2.3B | 5.12B | 6.45B | 6.79B |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 5.28B | 9.27B | 4.22B | 6.34B | 8.36B |
| Total Non-current Assets | 16.82B | 27.96B | 29.64B | 32.97B | 39.91B |
| Total Assets | 65.65B | 71.49B | 84.16B | 82.71B | 103.16B |
| Account Payables | 12.36B | 14.22B | 22.21B | 15.18B | 18B |
| Short-term Debt | 106.6M | 3.18B | 5.79B | 6.47B | 7.31B |
| Tax Payables | 96.49M | 78.8M | 356.01M | 450.08M | 0 |
| Deferred Revenue | 626.51M | 502.97M | 731.28M | 1.65B | 1.76B |
| Other Current Liabilities | 1.54B | 1.83B | 2.48B | 2.9B | 4.1B |
| Total Current Liabilities | 18.01B | 24.11B | 36.11B | 39.86B | 58.11B |
| Long-term Debt | 3.38B | 6.38B | 6.93B | 6.98B | 6.76B |
| Deferred Tax Liabilities | 0 | 0 | 404.02M | 341.93M | 330.35M |
| Deferred Revenue (Non-current) | 653.07M | 1.01B | 791.46M | 1.02B | 1.41B |
| Other Non-current Liabilities | 266.07M | 424.8M | 1.33B | 1.1B | 1.2B |
| Total Non-current Liabilities | 5.49B | 10.47B | 11.72B | 11.57B | 14.68B |
| Total Liabilities | 23.5B | 34.58B | 47.83B | 51.43B | 72.79B |
| Common Stock | 112K | 113K | 124K | 126K | 127K |
| Retained Earnings | (16.19B) | (25.33B) | (35.76B) | (41.59B) | (42.77B) |
| Accumulated OCI | (1.64B) | 1.55B | 1.89B | 2.19B | 1.9B |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 42.15B | 36.91B | 36.33B | 31.27B | 30.37B |
| Total Debt | 5.05B | 12.83B | 15.39B | 15.94B | 19.55B |
| Net Debt | (5.97B) | (1.78B) | (5.74B) | (2.65B) | 2.22B |
XPeng Inc.
NYSE:XPEV
Intrinsic Alpha fair value
Locked
Current Price
$9.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.